Navigation Links
Masimo Reports Second Quarter 2007 Financial Results
Date:9/19/2007

mpany's performance (in thousands, except share data):

Three Months Ended Six Months Ended

June 30, June 30,

2006 2007 2006 2007

Numerator:

GAAP net income $3,864 $2,798 $53,391 $5,110

Preferred stock dividend (1) - - 58,571 -

Accretion of preferred

stock (2) 1,956 1,956 4,073 3,913

Undistributed income

attributable to preferred

stockholder (3) 8,102 5,802 42,584 10,630

Non-GAAP net income 13,922 10,556 158,619 19,653

Denominator:

GAAP Weighted average number

of shares - Diluted 20,301,629 20,732,014 19,975,936 20,699,111

Weighted average

preferred shares (4) 34,612,503 34,612,503 34,612,503 34,612,503

Non-GAAP Weighted average

number of shares -

Diluted 54,914,132 55,344,517 54,588,439 55,311,614

Earnings per share - Diluted:

GAAP earnings per share $0.19 $0.13 $2.67 $0.25

Adjustments to if

converted method 0.06 0.06 0.24 0.11

Non-GAAP earnings per share $0.25 $0.19 $2.91 $0.36

Adjustments:

(1) Under the if converted method, no shares of preferred stock would

have been outstanding, therefore no dividends would have been

recorded specifically for preferred shareholders.

(2) Under the if converted method, no shares of preferred stock would

have been outstanding; therefore no allocation of undistributed

income to preferred stockholders would have been made.

(3) Under the if converted method, no shares
'/>"/>

SOURCE Masimo Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Calif. (PRWEB) June 02, 2015 ... build-to-order, independent blade-based and rackmount computing and storage ... announced the launch of its high density scale-out, ... Cirrascale Slipstream™ RM1622D . The high density, ... E3-1200 v4 product family with Intel® Iris™ Pro ...
(Date:6/2/2015)... Pa. , June 2, 2015   ... be attending the BIO Exhibition 2015 in ... Exhibition, the world,s largest biotechnology gathering, allows influential ... high-level executives, where they can evaluate emerging technologies ... significant eClinical expertise in the design, implementation and ...
(Date:6/2/2015)... Pa. , June 2, 2015   BioClinica ... and technology provider, today announced that David Peters ... been named Executive Vice President and Chief Financial Officer ... 2015. Peters brings more than 25 years ... pharmaceutical services. "David has extensive and deep knowledge in ...
(Date:6/2/2015)... June 2, 2015   Sigma-Aldrich Corporation (NASDAQ: ... Technology company, announced today it has entered into ... launch genetically engineered human neural differentiated cells and ... of neurological diseases. These new products, in combination ... versatile tools for the study of central nervous ...
Breaking Biology Technology:Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3YPrime at BIO Exhibition in Philadelphia and DIA in Washington DC during the month of June 2BioClinica Names David Peters New Chief Financial Officer 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 3
... (NASDAQ: ONTY ) today reported a net loss of ... for the quarter ended June 30, 2010 , compared with a net ... diluted share for the comparable period in 2009. Oncothyreon also reported a net ... diluted share for the six months ended June 30, 2010 , compared ...
... PRINCETON, N.J. , Aug. 5 Signum Biosciences, Inc. today ... Barrier Therapeutics, as Chief Executive Officer.  Dr. Shroot replaces Dr. Gregory ... a member of the board. , ... " Braham Shroot brings to Signum an outstanding ...
... Aug. 5 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... in the Phase I portion of its Phase I/II ... with myelofibrosis. In total, 21 patients were treated in ... shown significant activity in reducing spleen size and controlling ...
Cached Biology Technology:Oncothyreon reports second quarter 2010 financial results 2Oncothyreon reports second quarter 2010 financial results 3Oncothyreon reports second quarter 2010 financial results 4Oncothyreon reports second quarter 2010 financial results 5Oncothyreon reports second quarter 2010 financial results 6Oncothyreon reports second quarter 2010 financial results 7Oncothyreon reports second quarter 2010 financial results 8Signum Biosciences Names Braham Shroot as Chief Executive Officer 2YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study 2YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study 3YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study 4YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study 5
(Date:5/22/2015)... May 22, 2015 According to ... Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, Databases), ... and Utilities, Consumer and Home) - Global Forecast to ... from $2.77 Billion in 2015 to $6.19 Billion by ... Browse 79 market data Tables and   43 Figures ...
(Date:5/19/2015)... Sweden , May 18, 2015 ... fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one ... from June until and including Q3 2015 and the sensors ... . Communicated order values for 2015 hereby amount to ... for Q1 2015 of 140 MSEK and a number of ...
(Date:5/14/2015)... , May 14, 2015  Verificient ... identity verification and online remote proctoring, announced ... software-as-a-service (SaaS) company and creator of the ... of the two companies will benefit from ... Canvas. As a fully integrated ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
... molecular pathway could help physicians predict which lung cancer ... research from a multidisciplinary team at the University of ... suppressor, this fundamental molecule regulates cell proliferation in the ... either entirely inactive or altered in most human cancers. ...
... decade has witnessed an explosion of information regarding the ... development of obesity and the influence of peripheral, hormonal ... and metabolism. A symposium held recently in Washington, DC, ... work in talks by leaders in the field. ...
... mass extinction of life in Earths history 252 ... clam-like organisms called brachiopods dominated. After the calamity, when ... called a bivalve, took over. What can the ... surviving an extinction event" A lot, says UWM ...
Cached Biology News:UC health news: molecular pathway may predict chemotherapy effectiveness 2Obesity and the central nervous system -- the state of the art 2When bivalves ruled the world 2When bivalves ruled the world 3
CircuLex Anti-Human S100P Polyclonal Antibody Research Focus: proliferation Storage: -20C Shipping Temperature: 4C...
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
p38 MAP Kinase gamma Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Goat polyclonal to JIK ( Abpromise for all tested applications). Antigen: Synthetic peptide: HKKDHVFIRDEAGHGD, corresponding to amino acids 396-411 of Human JIK. Entrez Gene ID: 51347 Swi...
Biology Products: